TY - JOUR
T1 - Protocol
T2 - Examining the effectiveness of an adaptive implementation intervention to improve uptake of the VA suicide risk identification strategy: A sequential multiple assignment randomized trial
AU - Bahraini, Nazanin H.
AU - Matarazzo, Bridget B.
AU - Barry, Catherine N.
AU - Post, Edward P.
AU - Forster, Jeri E.
AU - Dollar, Katherine M.
AU - Dobscha, Steven K.
AU - Brenner, Lisa A.
N1 - Funding Information:
This research was supported by the Department of Veterans Affairs (VA) Quality Enhancement Research Initiative (QUERI PEC 19-303) and the Office of Mental Health and Suicide Prevention (OMHSP). Funders had no role in the design of the study or decision to submit the protocol for publication.
Funding Information:
This study is part of a larger national QI project (i.e., partnered evaluation) funded by VA Quality Enhancement Research Initiative (QUERI) and the Office of Mental Health and Suicide Prevention (OMHSP). The QI aims of this project are to evaluate the uptake of Risk ID across VHA facilities and to provide stepped implementation support to facilities that are not meeting a benchmark determined by OMHSP. This project will gather additional information from VHA employees to examine specific factors that may impact the uptake of Risk ID and the adoption of different implementation strategies. This information is intended to contribute to generalizable knowledge regarding organizational factors (e.g., organizational climate, leadership support) that can influence the implementation of evidence-based suicide prevention practices in general medical settings.
Publisher Copyright:
© 2020 The Author(s).
PY - 2020/7/22
Y1 - 2020/7/22
N2 - Background: In 2018, the Veterans Health Administration (VHA) mandated implementation of a national suicide risk identification strategy (Risk ID). The goal of Risk ID is to improve the detection and management of suicide risk by standardizing suicide risk screening and evaluation enterprise-wide. In order to ensure continuous quality improvement (QI), ongoing evaluation and targeted interventions to improve implementation of Risk ID are needed. Moreover, given that facilities will vary with respect to implementation needs and barriers, the dose and type of intervention needed may vary across facilities. Thus, the objective of this study is to examine the effectiveness of an adaptive implementation strategy to improve the uptake of suicide risk screening and evaluation in VHA ambulatory care settings. In addition, this study will examine specific factors that may impact the uptake of suicide risk screening and evaluation and the adoption of different implementation strategies. This protocol describes the stepped implementation approach and proposed evaluation plan. Methods: Using a sequential multiple assignment randomized trial (SMART) design, two evidence-based implementation strategies will be evaluated: (1) audit and feedback (A&F); (2) A&F plus external facilitation (A&F + EF). Implementation outcomes of interest include uptake of secondary suicide risk screening and uptake of comprehensive suicide risk evaluation (stages 2 and 3 of Risk ID). Secondary outcomes include rates of other clinical outcomes (i.e., safety planning) and organizational factors that may impact Risk ID implementation (i.e., leadership climate and leadership support). Discussion: This national QI study will use a SMART design to evaluate whether an adaptive implementation strategy is effective in improving uptake of a mandated VHA-wide suicide risk screening and evaluation initiative. If this study finds that the proposed stepped implementation strategy is effective at increasing uptake and maintaining performance improvements, this approach may be used as an overarching QI strategy for other national suicide prevention programs. Trial registration: ClinicalTrials.gov NCT04243330.
AB - Background: In 2018, the Veterans Health Administration (VHA) mandated implementation of a national suicide risk identification strategy (Risk ID). The goal of Risk ID is to improve the detection and management of suicide risk by standardizing suicide risk screening and evaluation enterprise-wide. In order to ensure continuous quality improvement (QI), ongoing evaluation and targeted interventions to improve implementation of Risk ID are needed. Moreover, given that facilities will vary with respect to implementation needs and barriers, the dose and type of intervention needed may vary across facilities. Thus, the objective of this study is to examine the effectiveness of an adaptive implementation strategy to improve the uptake of suicide risk screening and evaluation in VHA ambulatory care settings. In addition, this study will examine specific factors that may impact the uptake of suicide risk screening and evaluation and the adoption of different implementation strategies. This protocol describes the stepped implementation approach and proposed evaluation plan. Methods: Using a sequential multiple assignment randomized trial (SMART) design, two evidence-based implementation strategies will be evaluated: (1) audit and feedback (A&F); (2) A&F plus external facilitation (A&F + EF). Implementation outcomes of interest include uptake of secondary suicide risk screening and uptake of comprehensive suicide risk evaluation (stages 2 and 3 of Risk ID). Secondary outcomes include rates of other clinical outcomes (i.e., safety planning) and organizational factors that may impact Risk ID implementation (i.e., leadership climate and leadership support). Discussion: This national QI study will use a SMART design to evaluate whether an adaptive implementation strategy is effective in improving uptake of a mandated VHA-wide suicide risk screening and evaluation initiative. If this study finds that the proposed stepped implementation strategy is effective at increasing uptake and maintaining performance improvements, this approach may be used as an overarching QI strategy for other national suicide prevention programs. Trial registration: ClinicalTrials.gov NCT04243330.
UR - http://www.scopus.com/inward/record.url?scp=85088482036&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85088482036&partnerID=8YFLogxK
U2 - 10.1186/s13012-020-01019-6
DO - 10.1186/s13012-020-01019-6
M3 - Article
C2 - 32698812
AN - SCOPUS:85088482036
SN - 1748-5908
VL - 15
JO - Implementation Science
JF - Implementation Science
IS - 1
M1 - 58
ER -